CN106632833B - A kind of Injectable temperature sensitive hydrogel artificial crystalline lens material and preparation method thereof with cellular membrane biomimetic - Google Patents
A kind of Injectable temperature sensitive hydrogel artificial crystalline lens material and preparation method thereof with cellular membrane biomimetic Download PDFInfo
- Publication number
- CN106632833B CN106632833B CN201610929032.9A CN201610929032A CN106632833B CN 106632833 B CN106632833 B CN 106632833B CN 201610929032 A CN201610929032 A CN 201610929032A CN 106632833 B CN106632833 B CN 106632833B
- Authority
- CN
- China
- Prior art keywords
- temperature
- monomer
- sensitive hydrogel
- cellular membrane
- injectable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims abstract description 52
- 239000000017 hydrogel Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 230000003592 biomimetic effect Effects 0.000 title claims description 18
- 230000001413 cellular effect Effects 0.000 title claims 10
- 239000012528 membrane Substances 0.000 title claims 10
- 210000000695 crystalline len Anatomy 0.000 title 1
- 239000000178 monomer Substances 0.000 claims abstract description 62
- 239000003999 initiator Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical group N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000499 gel Substances 0.000 claims abstract description 15
- CEXQWAAGPPNOQF-UHFFFAOYSA-N 2-phenoxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1=CC=CC=C1 CEXQWAAGPPNOQF-UHFFFAOYSA-N 0.000 claims abstract description 6
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 claims abstract description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims abstract description 5
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical group CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000010526 radical polymerization reaction Methods 0.000 claims abstract description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- 239000011521 glass Substances 0.000 claims description 10
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 claims description 10
- 229950004354 phosphorylcholine Drugs 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 10
- 239000002861 polymer material Substances 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000002513 implantation Methods 0.000 claims description 8
- 230000036760 body temperature Effects 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 230000008961 swelling Effects 0.000 claims description 5
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 230000007704 transition Effects 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 238000001291 vacuum drying Methods 0.000 claims 1
- 210000000170 cell membrane Anatomy 0.000 abstract description 16
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical group CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 abstract description 8
- 230000003287 optical effect Effects 0.000 abstract description 7
- 239000011664 nicotinic acid Substances 0.000 abstract description 5
- RZVINYQDSSQUKO-UHFFFAOYSA-N 2-phenoxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC1=CC=CC=C1 RZVINYQDSSQUKO-UHFFFAOYSA-N 0.000 abstract description 4
- 210000002919 epithelial cell Anatomy 0.000 abstract description 4
- 230000035755 proliferation Effects 0.000 abstract description 4
- 208000002847 Surgical Wound Diseases 0.000 abstract description 3
- 238000002347 injection Methods 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- 235000001968 nicotinic acid Nutrition 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 9
- 230000021164 cell adhesion Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000002834 transmittance Methods 0.000 description 5
- 208000002177 Cataract Diseases 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000004313 glare Effects 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- -1 2-methacryloyloxyethyl phosphoryl Chemical group 0.000 description 1
- JRJNSEMUYTUGLA-UHFFFAOYSA-N 3-phenoxypropyl prop-2-enoate Chemical group C=CC(=O)OCCCOC1=CC=CC=C1 JRJNSEMUYTUGLA-UHFFFAOYSA-N 0.000 description 1
- 208000028006 Corneal injury Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/52—Amides or imides
- C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/30—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/30—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
- C08F220/301—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety and one oxygen in the alcohol moiety
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
本发明公开了一种细胞膜仿生的可注射温敏性水凝胶人工晶状体材料及其制备方法,属于生物医用材料领域。该材料由聚合单体和引发剂通过自有基聚合而成;其中聚合单体分为三种:第一种为N‑异丙基丙烯酰胺、乙烯基吡咯烷酮或甲基丙烯酸二甲胺乙酯等温敏性功能性单体;第二种为2‑苯氧乙基甲基丙烯酸酯或2‑苯氧乙基丙烯酸酯;第三种为2‑甲基丙烯酰氧乙基磷酰胆碱;引发剂为偶氮二异丁腈。本材料具有温敏性,低温下具有很好的水溶性及流动性,利于注射操作;在人体温度范围内,该材料发生凝胶化,具有很好的力学和光学性能;该人工晶状体具有细胞膜仿生的特点,生物相容性好,可减少人上皮细胞在人工晶状体表面的增生,通过注射手段有效降低手术切口。
The invention discloses an injectable temperature-sensitive hydrogel intraocular lens material with bionic cell membrane and a preparation method thereof, belonging to the field of biomedical materials. The material is formed by free-radical polymerization of polymerized monomers and initiators; the polymerized monomers are divided into three types: the first is N-isopropylacrylamide, vinylpyrrolidone or dimethylaminoethyl methacrylate Isotherm-sensitive functional monomer; the second is 2-phenoxyethyl methacrylate or 2-phenoxyethyl acrylate; the third is 2-methacryloyloxyethyl phosphorylcholine; The initiator is azobisisobutyronitrile. The material is temperature-sensitive, and has good water solubility and fluidity at low temperatures, which is convenient for injection operations; within the temperature range of the human body, the material gels and has good mechanical and optical properties; the intraocular lens has a cell membrane The characteristics of bionics and good biocompatibility can reduce the proliferation of human epithelial cells on the surface of the intraocular lens, and effectively reduce the surgical incision by means of injection.
Description
技术领域technical field
本发明属于生物医用材料领域,特别涉及具体涉及一种细胞膜仿生的可注射温敏性水凝胶人工晶状体材料及其制备方法。The invention belongs to the field of biomedical materials, in particular to a cell membrane bionic injectable temperature-sensitive hydrogel intraocular lens material and a preparation method thereof.
技术背景technical background
白内障是一种常见的中老年眼病,主要表现为晶体本身或晶体囊浑浊,临床上只能借助手术,即白内障摘除加人工晶状体植入使患者复明。人工晶状体已应用于临床数十年,主要是由多聚物和交联剂组成。通过改变多聚物的化学组成,可以改变人工晶状体的折射率、硬度等特性。根据其硬度,可以分为硬性人工晶状体和软性人工晶状体,而软性人工晶状体又称为可折叠人工晶状体。硬性人工晶状体的主要材料是聚甲基丙烯酸酯(PMMA),虽然具有光学性能好的特点,但是由于其硬度高,容易造成角膜损伤,在手术中有诸多限制。可折叠的人工晶状体是目前临床上应用广泛的产品,可折叠人工晶状体材料主要有硅凝胶,亲水性丙烯酸酯和疏水性丙烯酸酯。其材料具有很好的柔韧性,手术切口小,术后反应较轻。但是,由于折叠人工晶状体受材料和植入方式的限制,容易引起眩光问题以及后发型白内障。Cataract is a common middle-aged and elderly eye disease. It mainly manifests as opacity of the lens itself or the lens capsule. Clinically, surgery can only be used to restore vision to the patient, that is, cataract extraction and intraocular lens implantation. Intraocular lenses have been used clinically for decades and are mainly composed of polymers and cross-linking agents. By changing the chemical composition of the polymer, the refractive index, hardness and other properties of the intraocular lens can be changed. According to its hardness, it can be divided into hard intraocular lens and soft intraocular lens, and soft intraocular lens is also called foldable intraocular lens. The main material of rigid intraocular lens is polymethacrylate (PMMA). Although it has the characteristics of good optical performance, it is easy to cause corneal damage due to its high hardness, which has many limitations in surgery. Foldable intraocular lens is a product widely used clinically at present, and the materials of foldable intraocular lens mainly include silicone gel, hydrophilic acrylate and hydrophobic acrylate. The material has good flexibility, the surgical incision is small, and the postoperative reaction is light. However, because the folding intraocular lens is limited by materials and implantation methods, it is easy to cause glare problems and posterior cataracts.
发明内容Contents of the invention
本发明的目的在于一种细胞膜仿生的可注射温敏性水凝胶作为人工晶状体材料,提高其生物相容性,减少植入后的并发症以及上皮细胞在人工晶状体表面的增生。本发明提供的水凝胶材料,不同于其他人工晶状体材料,具有温敏性的特点,并在材料中引入了具有细胞膜仿生的2-甲基丙烯酰氧乙基磷酰胆碱组分,提高了材料的生物相容性。该组分的细胞膜仿生特点可以有效阻抗蛋白质和眼内上皮细胞在人工晶状体表面和内部粘附和增生,减少人工晶状体植入后的炎症和其他并发症。The purpose of the present invention is to use an injectable temperature-sensitive hydrogel with cell membrane bionics as an artificial lens material, improve its biocompatibility, reduce complications after implantation and the proliferation of epithelial cells on the surface of the artificial lens. The hydrogel material provided by the present invention is different from other intraocular lens materials in that it has the characteristics of temperature sensitivity, and introduces a bionic 2-methacryloyloxyethylphosphorylcholine component with cell membrane into the material to improve the biocompatibility of the material. The cell membrane bionic feature of this component can effectively resist the adhesion and proliferation of proteins and intraocular epithelial cells on the surface and interior of the intraocular lens, and reduce inflammation and other complications after implantation of the intraocular lens.
温敏性水凝胶在低温条件下具有很好的流动性,当调节温度达到设定温度时,材料发生凝胶,使其具有很好的力学强度。选择转变温度为人体温度的温敏性凝胶材料,在低温下注射入眼内,在体温条件下使其凝胶化,获得具有很好力学强度和光学性能的人工晶状体材料。这种植入方式可有效充满整个晶状体的囊袋,有效降低后发障,炫光等并发症。The temperature-sensitive hydrogel has good fluidity at low temperature. When the temperature is adjusted to reach the set temperature, the material will gel, making it have good mechanical strength. Select a temperature-sensitive gel material whose transition temperature is the temperature of the human body, inject it into the eye at low temperature, and gel it at body temperature to obtain an intraocular lens material with good mechanical strength and optical properties. This implantation method can effectively fill the capsular bag of the entire lens, effectively reducing complications such as hindrance and glare.
人工晶状体的生物相容性直接影响术后长期的视功能。针对人工晶状体表面改性大部分研究均着眼于通过构建生物惰性或低黏附力的表面来抑制细胞黏附,减少与周围组织的相互作用,这样的表面有利于抑制炎性反应。为了构建低黏附力的表面,提高材料表面的亲水性能降低其表面非特异性蛋白吸附作用,构建与蛋白具有同种电荷的改性层能进一步增加对该蛋白的抵抗吸附作用。The biocompatibility of intraocular lens directly affects the long-term visual function after operation. Most studies on the surface modification of intraocular lenses focus on inhibiting cell adhesion and reducing the interaction with surrounding tissues by constructing a biologically inert or low-adhesion surface, which is beneficial to inhibit inflammatory reactions. In order to construct a surface with low adhesion, improve the hydrophilicity of the surface of the material and reduce the non-specific protein adsorption on the surface, constructing a modified layer with the same charge as the protein can further increase the resistance to adsorption of the protein.
本发明通过以下技术方案来实现:The present invention is realized through the following technical solutions:
一种细胞膜仿生可注射温敏性水凝胶,由三种单体聚合而成,第一种单体为温敏性功能性单体;第二种单体为2-苯氧乙基甲基丙烯酸酯或2-苯氧乙基丙烯酸酯;第三种单体为2-甲基丙烯酰氧乙基磷酰胆碱。A cell membrane biomimetic injectable temperature-sensitive hydrogel, which is polymerized from three monomers, the first monomer is a temperature-sensitive functional monomer; the second monomer is 2-phenoxyethylmethyl acrylate or 2-phenoxyethyl acrylate; the third monomer is 2-methacryloyloxyethyl phosphorylcholine.
作为可选方式,在上述细胞膜仿生温敏性水凝胶中,所述温敏性功能性单体为N-异丙基丙烯酰胺或乙烯基吡咯烷酮或甲基丙烯酸二甲胺乙酯。As an option, in the above cell membrane biomimetic temperature-sensitive hydrogel, the temperature-sensitive functional monomer is N-isopropylacrylamide or vinylpyrrolidone or dimethylaminoethyl methacrylate.
作为可选方式,在上述细胞膜仿生温敏性水凝胶中,第一种单体的用量占聚合单体总质量的20%~45%;第二种单体的用量占聚合单体总质量的20%~45%;第三种单体的用量占聚合单体总质量的10%~35%As an alternative, in the above cell membrane biomimetic thermosensitive hydrogel, the amount of the first monomer accounts for 20% to 45% of the total mass of the polymerized monomers; the amount of the second monomer accounts for 20% to 45% of the total mass of the polymerized monomers; 20%~45% of the total mass of the polymerized monomers; the amount of the third monomer accounts for 10%~35% of the total mass of the polymerized monomers
作为可选方式,在上述细胞膜仿生可注射温敏性水凝胶中,该材料由聚合单体、温敏性功能性单体和引发剂通过自由基聚合而成。As an alternative, in the above cell membrane biomimetic injectable temperature-sensitive hydrogel, the material is formed by free radical polymerization of polymerized monomers, temperature-sensitive functional monomers and initiators.
作为可选方式,在上述细胞膜仿生可注射温敏性水凝胶中,所述引发剂为偶氮二异丁腈。As an alternative, in the above cell membrane biomimetic injectable temperature-sensitive hydrogel, the initiator is azobisisobutyronitrile.
作为可选方式,在上述细胞膜仿生可注射温敏性水凝胶中,所述引发剂的用量占聚合物单体总质量的0.1%~2%。As an alternative, in the above cell membrane biomimetic injectable temperature-sensitive hydrogel, the amount of the initiator accounts for 0.1%-2% of the total mass of the polymer monomers.
作为可选方式,所述细胞膜仿生可注射温敏性水凝胶材料,具有大于1.5的折光指数,光线透过率超过90%,形变回复率超过95%,适合作为人工晶状体材料。As an option, the cell membrane bionic injectable temperature-sensitive hydrogel material has a refractive index greater than 1.5, a light transmittance of more than 90%, and a deformation recovery rate of more than 95%, which is suitable as an intraocular lens material.
本发明还提供了一种上述可注射细胞膜仿生可注射温敏性水凝胶的制备方法,其特征在于,将所述三种单体与引发剂进行自有基聚合而成。The present invention also provides a preparation method of the injectable cell membrane biomimetic injectable temperature-sensitive hydrogel, which is characterized in that the three monomers and an initiator are subjected to free-radical polymerization.
作为可选方式,在上述制备方法中,将聚合单体与引发剂混合后在真空条件下50ºC~100ºC反应0.5~24 h,分离产物去除未反应的小分子单体,即得到温敏性水凝胶。As an alternative, in the above preparation method, the polymerized monomer and the initiator are mixed and then reacted at 50ºC~100ºC for 0.5~24 h under vacuum conditions, and the product is separated to remove unreacted small molecule monomers to obtain temperature-sensitive water gel.
作为可选方式,在上述制备方法中,将聚合单体,温敏性功能性单体与引发剂按照一定比例在氮气保护下进行混合;混合均匀后注入玻璃模具中,然后置于真空烘箱中;首先在50 ºC~70 ºC反应0.5~24 h, ,然后将温度升至80~100 ºC,继续反应1~24小时。 反应结束后,将玻璃模具置于40ºC去离子水中进行溶胀平衡,聚合物材料脱模,期间通过更换去离子水去除未反应的小分子单体,最终得到敏性聚合物材料。As an alternative, in the above preparation method, the polymerized monomer, the temperature-sensitive functional monomer and the initiator are mixed according to a certain ratio under the protection of nitrogen; after mixing evenly, pour it into a glass mold, and then place it in a vacuum oven ; First react at 50 ºC~70 ºC for 0.5~24 h, then raise the temperature to 80~100 ºC and continue the reaction for 1~24 hours. After the reaction, the glass mold was placed in 40ºC deionized water for swelling balance, and the polymer material was released from the mold. During this period, unreacted small molecular monomers were removed by replacing the deionized water, and finally a sensitive polymer material was obtained.
本发明中通过调整单体配比来调整材料的凝胶转变温度,得到机械性能、光学性能良好的水凝胶作为人工晶状体材料;具有大于1.5的折光指数,光线透过率超过90%,形变回复率超过95%,适合作为人工晶状体材料。In the present invention, the gel transition temperature of the material is adjusted by adjusting the ratio of the monomers to obtain a hydrogel with good mechanical properties and optical properties as the intraocular lens material; it has a refractive index greater than 1.5, and the light transmittance exceeds 90%. The recovery rate exceeds 95%, which is suitable as an intraocular lens material.
本发明还提供了一种上述的细胞膜仿生温敏性水凝胶的应用,其特征在于,将其用于可细胞膜仿生的温敏性人工晶状体。The present invention also provides an application of the above-mentioned cell membrane biomimetic temperature-sensitive hydrogel, which is characterized in that it is used in a temperature-sensitive intraocular lens capable of cell membrane biomimesis.
本说明书中公开的所有特征,或公开的所有方法或过程中的步骤,除了互相排斥的特征和/或步骤以外,均可以以任何方式组合。All features disclosed in this specification, or steps in all methods or processes disclosed, may be combined in any manner, except for mutually exclusive features and/or steps.
本发明的有益效果:Beneficial effects of the present invention:
本发明作为人工晶状体材料的可注射温敏性水凝胶,通过注射的植入方式有效地减小了手术切口,避免术后并发症的出现;由于含有具有细胞膜仿生的磷酰胆碱成分,使得材料具有高度的生物相容性,可以有效阻抗蛋白质和眼内上皮细胞在人工晶状体表面和内部粘附和增生,减少人工晶状体植入后的炎症反应。同时,有效避免疏水性人工晶状体植入眼内的微泡现象和镜面效应所致的眩光问题。The injectable temperature-sensitive hydrogel used as the intraocular lens material of the present invention can effectively reduce the surgical incision through the injection implantation method and avoid the occurrence of postoperative complications; The material has a high degree of biocompatibility, which can effectively resist the adhesion and proliferation of proteins and intraocular epithelial cells on the surface and interior of the intraocular lens, and reduce the inflammatory response after implantation of the intraocular lens. At the same time, it can effectively avoid the glare problem caused by the microbubble phenomenon and the mirror effect of the hydrophobic intraocular lens implanted in the eye.
具体实施方式:Detailed ways:
以下通过实施例的具体实施方式再对本发明的上述内容作进一步的详细说明。应当理解,此处所描述的具体实例仅仅用以解释本发明,并不用于限定本发明。在不脱离本发明的精神和原则之内做的任何修改,以及根据本领域普通技术知识和惯用手段做出的等同替换或者改进,均应包括在本发明的保护范围内。The above-mentioned content of the present invention will be further described in detail through the specific implementation of the examples below. It should be understood that the specific examples described here are only used to explain the present invention, not to limit the present invention. Any modification made without departing from the spirit and principles of the present invention, as well as equivalent replacements or improvements made according to ordinary technical knowledge and conventional means in the field shall be included in the protection scope of the present invention.
以下实施例中所用部分原料结构式如下表所示:Part of the raw material structural formula used in the following examples is shown in the table below:
实施例1:Example 1:
选用单体:第一种单体为N-异丙基丙烯酰胺,第二种单体为2-苯氧乙基丙烯酸酯,第三种单体2-甲基丙烯酰氧乙基磷酰胆碱,引发剂为偶氮二异丁腈。其中N-异丙基丙烯酰胺含量为40%,2-苯氧乙基丙烯酸酯为40%,2-甲基丙烯酰氧乙基磷酰胆碱为19%,偶氮二异丁腈1%。将可聚合单体和引发剂在氮气保护下混合均匀后注入玻璃模具,在烘箱内60ºC加热聚合18小时,然后将温度升至90ºC,继续反应6小时。将玻璃模具置于40 ºC的去离子水中进行溶胀平衡,聚合物材料脱模,期间通过更换去离子水去除未反应的小分子单体,最终得到能够作为人工晶状体材料的温敏性聚合物材料。该材料在12 ºC以下水溶性好,具有很好的流动性,可进行注射操作;当温度在体温37 ºC时,该聚合物的水溶液迅速凝胶化,具有很好的力学强度和光学性能;该凝胶材料的屈光指数为1.52,37 ºC凝胶时间为5 min,平衡水含量为15%,光线透过率大于90%,形变回复率超过95%。Selected monomers: the first monomer is N-isopropylacrylamide, the second monomer is 2-phenoxyethyl acrylate, and the third monomer is 2-methacryloyloxyethyl phosphoryl chol The base, the initiator is azobisisobutyronitrile. Among them, the content of N-isopropylacrylamide is 40%, 2-phenoxyethyl acrylate is 40%, 2-methacryloyloxyethyl phosphorylcholine is 19%, and azobisisobutyronitrile is 1%. . The polymerizable monomer and the initiator were mixed uniformly under the protection of nitrogen and injected into the glass mold, heated and polymerized in an oven at 60ºC for 18 hours, then the temperature was raised to 90ºC, and the reaction was continued for 6 hours. Put the glass mold in deionized water at 40 ºC for swelling balance, and the polymer material is demoulded. During this period, the unreacted small molecular monomers are removed by replacing the deionized water, and finally a temperature-sensitive polymer material that can be used as an intraocular lens material is obtained . The material has good water solubility below 12 ºC, has good fluidity, and can be injected; when the temperature is 37 ºC at body temperature, the aqueous solution of the polymer gels rapidly, and has good mechanical strength and optical properties; The gel material has a refractive index of 1.52, a gel time of 5 minutes at 37 ºC, an equilibrium water content of 15%, a light transmittance of more than 90%, and a deformation recovery rate of more than 95%.
HUVEC细胞黏附实验:将HUVEC细胞在37 ºC培养48 h后在荧光显微镜观察。结果如图1所示,A图为不含磷酸胆碱的聚合物材料,可以看出表面黏附大量细胞,B图显示含有磷酸胆碱材料表面黏附细胞情况,表明经过磷酸胆碱修饰材料具有很好的抗细胞黏附性能,这是由于磷酸胆碱两性离子使得材料表面形成水合层,有效的阻止细胞的黏附。本实施例所得材料具有优异的抗细胞黏附性能。HUVEC cell adhesion experiment: HUVEC cells were cultured at 37 ºC for 48 h and observed under a fluorescence microscope. The results are shown in Figure 1. Figure A shows the polymer material without phosphorylcholine, and it can be seen that a large number of cells adhere to the surface. Figure B shows the adhesion of cells on the surface of the material containing phosphorylcholine, indicating that the phosphorylcholine-modified material has a large Good anti-cell adhesion performance, this is because the phosphorylcholine zwitterion makes the surface of the material form a hydration layer, which effectively prevents cell adhesion. The material obtained in this example has excellent anti-cell adhesion properties.
实施例2:Example 2:
选用单体:第一种单体为乙烯基吡咯烷酮,第二种单体为2-苯氧乙基甲基丙烯酸酯,第三种单体2-甲基丙烯酰氧乙基磷酰胆碱,引发剂为偶氮二异丁腈。其中乙烯基吡咯烷酮含量为40%,2-苯氧乙基甲基丙烯酸酯为45%,2-甲基丙烯酰氧乙基磷酰胆碱为14%,偶氮二异丁腈1%。将可聚合单体、引发剂在氮气保护下混合均匀后注入玻璃模具,在烘箱内70 ºC加热聚合8小时,然后将温度升至100 ºC,继续反应12小时。将玻璃模具置于去40 ºC的离子水中进行溶胀平衡,聚合物脱模,期间通过更换去离子水去除未反应的小分子单体,最终得到能够作为人工晶状体材料的温敏性聚合物材料。该材料在15 ºC以下具有很好的水溶性,具有很好的流动性,可进行注射操作;当温度在体温37 ºC时,该聚合物的水溶液迅速凝胶化,具有很好的力学强度和光学性能;该材料的屈光指数为1.5,37 ºC凝胶时间为10min,平衡水含量为12%,光线透过率大于90%,形变回复率超过95%。Selected monomers: the first monomer is vinylpyrrolidone, the second monomer is 2-phenoxyethyl methacrylate, the third monomer is 2-methacryloyloxyethyl phosphorylcholine, The initiator is azobisisobutyronitrile. Among them, the content of vinylpyrrolidone is 40%, 2-phenoxyethyl methacrylate is 45%, 2-methacryloyloxyethyl phosphorylcholine is 14%, and azobisisobutyronitrile is 1%. The polymerizable monomer and initiator were mixed evenly under the protection of nitrogen and then injected into a glass mold, heated and polymerized in an oven at 70 ºC for 8 hours, and then the temperature was raised to 100 ºC to continue the reaction for 12 hours. The glass mold was placed in deionized water at 40 ºC for swelling balance, and the polymer was released from the mold. During this period, the unreacted small molecular monomers were removed by replacing the deionized water, and finally a temperature-sensitive polymer material that could be used as an intraocular lens material was obtained. The material has good water solubility below 15 ºC, has good fluidity, and can be injected; when the temperature is 37 ºC at body temperature, the aqueous solution of the polymer gels rapidly, has good mechanical strength and Optical properties: The material has a refractive index of 1.5, a gel time of 10 minutes at 37 ºC, an equilibrium water content of 12%, a light transmittance of more than 90%, and a deformation recovery rate of more than 95%.
HUVEC细胞黏附实验:将HUVEC细胞在37 ºC培养48 h后在荧光显微镜观察。结果如图2所示,A图为不含磷酸胆碱的聚合物材料,可以看出表面黏附大量细胞,B图显示含有磷酸胆碱材料表面黏附细胞情况,表明经过磷酸胆碱修饰材料具有很好的抗细胞黏附性能,这是由于磷酸胆碱两性离子使得材料表面形成水合层,有效的阻止细胞的黏附。本实施例所得材料具有优异的抗细胞黏附性能。HUVEC cell adhesion experiment: HUVEC cells were cultured at 37 ºC for 48 h and observed under a fluorescence microscope. The results are shown in Figure 2. Figure A shows the polymer material without phosphorylcholine, and it can be seen that a large number of cells adhere to the surface. Figure B shows the adhesion of cells on the surface of the phosphorylcholine-containing material, indicating that the phosphorylcholine-modified material has a large Good anti-cell adhesion performance, this is because the phosphorylcholine zwitterion makes the surface of the material form a hydration layer, which effectively prevents cell adhesion. The material obtained in this example has excellent anti-cell adhesion properties.
实施例3:Example 3:
选用单体:第一种单体为甲基丙烯酸二甲胺乙酯,第二种单体为2-苯氧乙基甲基丙烯酸酯,第三种单体2-甲基丙烯酰氧乙基磷酰胆碱,引发剂为偶氮二异丁腈。其中甲基丙烯酸二甲胺乙酯含量为43%,2-苯氧乙基甲基丙烯酸酯为42%,2-甲基丙烯酰氧乙基磷酰胆碱为14%,偶氮二异丁腈1%。将可聚合单体和引发剂在氮气保护下混合均匀后注入玻璃模具,在烘箱内60 ºC加热聚合16小时,然后将温度升至100ºC,继续反应8小时。将玻璃模具置于40 ºC的去离子水中进行溶胀平衡,聚合物脱模,期间通过更换去离子水去除未反应的小分子单体,最终得到能够作为人工晶状体材料的温敏性聚合物材料。该材料在7 ºC以下具有很好的水溶性,具有很好的流动性,可进行注射操作;当温度在体温37 ºC时,该聚合物的水溶液迅速凝胶化,具有很好的力学强度和光学性能;该材料的屈光指数为1.54,37 ºC凝胶时间为7 min,平衡水含量为17%,光线透过率大于90%,形变回复率超过95%。Selected monomers: the first monomer is dimethylaminoethyl methacrylate, the second monomer is 2-phenoxyethyl methacrylate, and the third monomer is 2-methacryloyloxyethyl Phosphorylcholine, the initiator is azobisisobutyronitrile. Among them, the content of dimethylaminoethyl methacrylate is 43%, 2-phenoxyethyl methacrylate is 42%, 2-methacryloyloxyethyl phosphorylcholine is 14%, azobisisobutyl Nitrile 1%. The polymerizable monomer and the initiator were mixed uniformly under the protection of nitrogen and injected into the glass mold, heated and polymerized in an oven at 60 ºC for 16 hours, and then the temperature was raised to 100 ºC to continue the reaction for 8 hours. The glass mold was placed in deionized water at 40 ºC for swelling balance, and the polymer was released from the mold. During this period, unreacted small molecular monomers were removed by replacing the deionized water, and finally a temperature-sensitive polymer material that could be used as an intraocular lens material was obtained. The material has good water solubility below 7 ºC, has good fluidity, and can be injected; when the temperature is 37 ºC at body temperature, the aqueous solution of the polymer gels rapidly, has good mechanical strength and Optical properties: The material has a refractive index of 1.54, a gel time of 7 minutes at 37 ºC, an equilibrium water content of 17%, a light transmittance of more than 90%, and a deformation recovery rate of more than 95%.
HUVEC细胞黏附实验:将HUVEC细胞在37 ºC培养48 h后在荧光显微镜观察。结果如图3所示,A图为不含磷酸胆碱的聚合物材料,可以看出表面黏附大量细胞,B图显示含有磷酸胆碱材料表面黏附细胞情况,表明经过磷酸胆碱修饰材料具有很好的抗细胞黏附性能,这是由于磷酸胆碱两性离子使得材料表面形成水合层,有效的阻止细胞的黏附。本实施例所得材料具有优异的抗细胞黏附性能。HUVEC cell adhesion experiment: HUVEC cells were cultured at 37 ºC for 48 h and observed under a fluorescence microscope. The results are shown in Figure 3. Figure A shows the polymer material without phosphorylcholine, and it can be seen that a large number of cells adhere to the surface. Figure B shows the adhesion of cells on the surface of the phosphorylcholine-containing material, indicating that the phosphorylcholine-modified material has a large Good anti-cell adhesion performance, this is because the phosphorylcholine zwitterion makes the surface of the material form a hydration layer, which effectively prevents cell adhesion. The material obtained in this example has excellent anti-cell adhesion properties.
以上所述仅为本发明的优选实施例,对本发明而言,仅仅是说明性的,而非限制性的;本领域普通技术人员理解,在本发明专利要求所限定的范围内,可对其进行许多改变、修改,甚至等效变更,但都将落入本发明的保护范围。The above is only a preferred embodiment of the present invention, and for the present invention, it is only illustrative and not restrictive; those of ordinary skill in the art understand that within the scope of the patent requirements of the present invention, they can Many changes, modifications, and even equivalent changes can be made, but all will fall within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610929032.9A CN106632833B (en) | 2016-10-31 | 2016-10-31 | A kind of Injectable temperature sensitive hydrogel artificial crystalline lens material and preparation method thereof with cellular membrane biomimetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610929032.9A CN106632833B (en) | 2016-10-31 | 2016-10-31 | A kind of Injectable temperature sensitive hydrogel artificial crystalline lens material and preparation method thereof with cellular membrane biomimetic |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106632833A CN106632833A (en) | 2017-05-10 |
CN106632833B true CN106632833B (en) | 2018-12-07 |
Family
ID=58820313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610929032.9A Active CN106632833B (en) | 2016-10-31 | 2016-10-31 | A kind of Injectable temperature sensitive hydrogel artificial crystalline lens material and preparation method thereof with cellular membrane biomimetic |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106632833B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108578768B (en) * | 2018-03-23 | 2020-05-01 | 四川大学 | High-strength injectable intraocular lens material and preparation method and application thereof |
CN112353948B (en) * | 2020-10-21 | 2021-08-27 | 四川大学 | Drug-loaded micelle responding to acidic microenvironment to realize particle size reduction and surface charge inversion and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101918865A (en) * | 2008-01-14 | 2010-12-15 | 库柏维景国际控股公司 | Polymerizable contact lens formulations and contact lenses obtained therefrom |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2890316B2 (en) * | 1989-07-07 | 1999-05-10 | 科学技術振興事業団 | Materials for biocompatible medical devices |
KR101242658B1 (en) * | 2010-10-11 | 2013-03-19 | 한국과학기술연구원 | Hydrophilic Intraocular Lens Having High Refractive Index and a Method for Preparing Same |
-
2016
- 2016-10-31 CN CN201610929032.9A patent/CN106632833B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101918865A (en) * | 2008-01-14 | 2010-12-15 | 库柏维景国际控股公司 | Polymerizable contact lens formulations and contact lenses obtained therefrom |
Also Published As
Publication number | Publication date |
---|---|
CN106632833A (en) | 2017-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3725431B2 (en) | Water plasticized high refractive index polymer for the eye | |
JP5432133B2 (en) | Monomer composition for silicon hydrogel for soft contact lens and soft contact lens produced by the monomer composition | |
EP0811393B1 (en) | Soft intraocular lens | |
KR102295439B1 (en) | (meth)acrylamid polymers for contact lens and intraocular lens | |
US9820850B2 (en) | Polymers and methods for ophthalmic applications | |
US20020042484A1 (en) | High refractive index hydrogel compositions for ophthalmic implants | |
CN101564551B (en) | Acrylic acid ester shape-memory intraocular lens material and preparation method thereof | |
CN112292100A (en) | Composition with high reaction index and high dispersion coefficient | |
NZ250817A (en) | Polymer comprising hydrophilic monomer units and units of a branched hydroxyalkyl(meth)acrylate or -(meth)acrylamide; ophthalmic lenses | |
CN105536053B (en) | A kind of hydrophily shape memory gel as artificial crystalline lens material | |
US10106637B2 (en) | Polymers and methods for ophthalmic applications | |
CN106632833B (en) | A kind of Injectable temperature sensitive hydrogel artificial crystalline lens material and preparation method thereof with cellular membrane biomimetic | |
JP2023052498A (en) | Polymers and methods for ophthalmic applications | |
WO2000079312A1 (en) | High refractive index compositions for ophthalmic implants | |
WO2019228224A1 (en) | Polymer material and intraocular lens | |
CN107325240B (en) | A kind of polymerizable ZnS nanoparticle, preparation method and its it is used to prepare the high method for reflecting ophthalmically acceptable correction of refractive errors material | |
US20230131507A1 (en) | Bioactive polymers for ophthalmic applications | |
WO2013110911A1 (en) | Silicone hydrogels and methods for manufacture | |
TW202229377A (en) | Modifier for ophthalmological device | |
CN118978631A (en) | A hydrogel lens and a method for preparing the same | |
Tayal | Hydrophilic acrylics: polymerisation kinetics, adsorption/desorption isotherms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |